Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: A multicentre cohort study Disease epidemiology - Infectious

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Raffetti, Elena ^a   Albini, Laura ^a   Gotti, Daria ^a   Segala, Daniela ^b   Maggiolo, Franco ^c   Di Filippo, Elisa ^c   Saracino, Annalisa ^d   Ladisa, Nicoletta ^d   Lapadula, Giuseppe ^e   Fornabaio, Chiara ^f   Castelnuovo, Filippo ^g   Casari, Salvatore ^a   Fabbiani, Massimiliano ^h   Pierotti, Piera ⁱ   Donato, Francesco ^a   Quiros Roldan, Eugenia ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^d POLICLINICO   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

^f Clinic of Infectious Diseases Istituti Ospitalieri   (Italy)

^g SPEDALI CIVILI   (Italy)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

Cancer; Epidemiology; HIV infection; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE; AGED; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HIV INFECTIONS; HUMAN; INCIDENCE; ITALY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOPLASMS; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE; YOUNG ADULT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84925252838     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1565-0     Document Type: Article

References (37)

1. Guaraldi G, Cossarizza A, Franceschi C, Roverato A, Vaccher E, Tambussi G, et al. Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy. JAIDS. 2014;65(2):175-81.
2. Galli L, Spagnuolo V, Salpietro S, Gianotti N, Cossarini F, Lazzarin A, et al. Mortality of HIV-infected patients with or without cancer: comparison with the general population in Italy. Antivir Ther. 2012;17(3):447-58.
3. Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med. 2013;14:195-207.
4. Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241-8.
5. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy,1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50(10):1387-96.
6. McManus H, O'Connor CC, Boyd M, Broom J, Russell D, Watson K, et al. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy. PLoS One. 2012;7(11):e48839.
7. Simmons R, Ciancio B, Rice BD KM, Delpech VC. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer. HIV Med. 2013;14(10):596-604.
8. Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, et al. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy, 1999-2009. HIV Med. 2013;14(8):481-90.
9. Albini L, Calabresi A, Gotti D, Ferraresi A, Festa A, Donato F, et al. Burden of Non-AIDS-defining and Non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy Era. AIDS Res Hum Retroviruses. 2013;29(8):1097-104.
10. Simard EP, Pfeiffer RM, Engels EA. Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods. AIDS. 2012;26(10):1311-8.
11. Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS. 2010;24(10):1537-48.
12. Van Sighem A, Danner S, Ghani AC, Gras L, Anderson RM, de Wolf F, et al. Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2005;40(2):212-8.
13. Dal Maso L, Suligoi B, Franceschi S, Braga C, Buzzoni C, Polesel J, et al. Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation. J Acquir Immune Defic Syndr. 2014;66(4):428-35.
14. Zucchetto A, Suligoi B, De Paoli A, Pennazza S, Polesel J, Bruzzone S, et al. Excess mortality for non-AIDS-defining cancers among people with AIDS. Clin Infect Dis. 2010;51(9):1099-101.
15. Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer. 2010;127(6):1437-45.
16. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009;100(5):840-7.
17. Dorrucci M, Balducci M, Pezzotti P, Sinicco A, Alberici F, Rezza G, et al. Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. Italian HIV Seroconversion Study (ISS). J Acquir Immune Defic Syndr. 1999;22(1):65-70.
18. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, et al. All-cause mortality in treated HIV-infected adults with CD4500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433-4.
19. MASTER Cohort. website http://www.mastercohort.it. Last access 23th October 2014.
20. May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, et al. Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol. 2012;41:1807-20.
21. World Health Organization. International Classification of Disease (ICD)-10 http://www.who.int/classifications/icd/en/. Last access 23th October 2014.
22. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-60.
23. Ramqvist T, Dalianis T. Oropharyngeal cancer epidemic and humanpapillomavirus. Emerg Infect Dis. 2010;16(11):1671-7.
24. Cobucci RN, Lima PH, de Souza PC, Costa VV, Cornetta MD, Fernandes JV, et al. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review. J Infect Public Health. 2015;8(1):1-10.
25. Vaccher E, Serraino D, Carbone A, De Paoli P. The evolving scenario of non AIDS-defining cancers: challenges and opportunities of care. Oncologist. 2014;19(8):860-7.
26. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51-9.
27. Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, et al. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3on long term combination antiretroviral therapy reach same mortality rates as the general population. JAIDS. 2007;46:72-7.
28. The Antiretroviral Therapy Cohort Collaboration, Zwahlen M, Harris R, May M, Hogg R, Costagliola D, et al. Mortality of HIV-infected patients starting potent anti-retroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol. 2009;38:1624-33.
29. Lewden C, Raffi F, Chene G, Sobel A, Leport C, TheAPROCO Study Group. Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy - standardization to the general population. JAIDS. 2001;26:480-82.
30. Jaggy C, von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet. 2003;362:877-78.
31. Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, et al. All-cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18:1835-43.
32. Martinez E, Milinkovic A, Buira E, de Lazzari E, León A, Larrousse M, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med. 2007;8:251-58.
33. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012;175(4):302-8.
34. Hernando V, Perez-Cachafeiro S, Lewden C, Gonzalez J, Segura F, Oteo JA, et al. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. J Hepatol. 2012;57(4):743-51.
35. Klein MB, Rollet-Kurhajec KC, Moodie EE, Yaphe S, Tyndall M, Walmsley S, et al. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013). AIDS. 2014;28(13):1957-65.
36. van Santen DK, van der Helm JJ, Grady BP, de Vos AS, Kretzschmar ME, Stolte IG, et al. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status. AIDS. 2014;28(17):2589-99.
37. Denis B, Guiguet M, de Castro N, Mechaï F, Revest M, Mahamat A, et al. Critical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort. PLoS One. 2014;9(4):e94183.